Can-Fite BioPharma Ltd. - SPONSORED ADR (CANF)

Historical Portfolio Holders from Q1 2023 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / SPONSORED ADR
Shares, excl. options Q3 2024
754K
Holdings value Q3 2024
$1.52M
Value change Q3 2024
+$243K
Grand Portfolio weight change Q3 2024
+0%
Number of holders
11
Number of buys Q3 2024
4
Number of sells Q3 2024
-3
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 754K $1.52M +$243K $2.01 11
2024 Q2 628K $1.62M +$393K $2.58 11
2024 Q1 478K $1.06M +$519K $2.22 8
2023 Q4 244K $536K +$382K $2.20 8
2023 Q3 67.6K $179K +$34.5K $2.65 8
2023 Q2 54.6K $168K -$705K $3.07 5
2023 Q1 368K $843K +$843K $2.29 6